Anxiolytic (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anxiolytic" in English language version.

refsWebsite

Global rank English rank

52nih.gov

4^th place

36doi.org

2^nd place

24worldcat.org

5^th place

11semanticscholar.org

11^th place

8^th place

3web.archive.org

1^st place

3clevelandclinic.org

4,925^th place

3,597^th place

1camh.ca

low place

1klarityadhd.com

low place

1psychcentral.com

9,619^th place

7,824^th place

1springer.com

274^th place

309^th place

1nhs.uk

1,989^th place

1,528^th place

1mayoclinic.org

1,610^th place

1,279^th place

1zenodo.org

621^st place

380^th place

1books.google.com

3^rd place

1rmj.ru

9,799^th place

low place

1handle.net

102^nd place

76^th place

1olainfarm.lv

low place

1inist.fr

2,854^th place

3,669^th place

1thefreedictionary.com

614^th place

572^nd place

1farmak.ua

low place

books.google.com

Annual Reports in Medicinal Chemistry, Volume 32 p. 319

camh.ca

"Anxiety: Pharmacotherapy". CAMH. Retrieved 15 January 2024.

clevelandclinic.org

my.clevelandclinic.org

"Anxiolytics and you: How anxiety medications can help". Cleveland Clinic. Retrieved 15 January 2024.
"Benzodiazepines: What They Are, Uses, Side Effects & Risks". Cleveland Clinic. Retrieved 15 January 2024.
"Serotonin: What Is It, Function & Levels". Cleveland Clinic. Retrieved 15 January 2024.

doi.org

Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Van Der Walt, Martie; Keddy, Karen H. (1 June 2021). "The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future". Frontiers in Psychiatry. 12: 617751. doi:10.3389/fpsyt.2021.617751. ISSN 1664-0640. PMC 8203803. PMID 34140898.
Hillhouse, Todd M.; Porter, Joseph H. (2015). "A brief history of the development of antidepressant drugs: From monoamines to glutamate". Experimental and Clinical Psychopharmacology. 23 (1): 1–21. doi:10.1037/a0038550. ISSN 1936-2293. PMC 4428540. PMID 25643025.
"Rang and Dale's Pharmacology 7th Edition Preface", Rang &amp Dale's Pharmacology, Elsevier, pp. xv, 2012, doi:10.1016/b978-0-7020-3471-8.00064-0, ISBN 9780702034718, retrieved 16 March 2022
Garakani, Amir; Murrough, James W.; Freire, Rafael C.; Thom, Robyn P.; Larkin, Kaitlyn; Buono, Frank D.; Iosifescu, Dan V. (2020). "Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options". Frontiers in Psychiatry. 11. doi:10.3389/fpsyt.2020.595584. ISSN 1664-0640. PMC 7786299. PMID 33424664.
Lochmann, Dee; Richardson, Tara (2018), Macaluso, Matthew; Preskorn, Sheldon H. (eds.), "Selective Serotonin Reuptake Inhibitors", Antidepressants, vol. 250, Cham: Springer International Publishing, pp. 135–144, doi:10.1007/164_2018_172, ISBN 978-3-030-10948-6, PMID 30838457, retrieved 16 March 2022
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety disorders". Generalized Anxiety Disorders. 19 (2): 93–107. doi:10.31887/dcns.2017.19.2/bbandelow. ISSN 2608-3477. PMC 5573566. PMID 28867934.
Thanacoody, H. K. Ruben; Thomas, Simon H. L. (2005). "Tricyclic antidepressant poisoning : cardiovascular toxicity". Toxicological Reviews. 24 (3): 205–214. doi:10.2165/00139709-200524030-00013. ISSN 1176-2551. PMID 16390222. S2CID 44532041.
Montano, C. Brendan; Jackson, W. Clay; Vanacore, Denise; Weisler, Richard (4 July 2023). "Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression". Postgraduate Medicine. 135 (5): 449–465. doi:10.1080/00325481.2023.2189868. ISSN 0032-5481. PMID 36912037.
Tanghe, A.; Geerts, S.; Van Dorpe, J.; Brichard, B.; Bruhwyler, J.; Géczy, J. (August 1997). "Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression". Acta Psychiatrica Scandinavica. 96 (2): 134–141. doi:10.1111/j.1600-0447.1997.tb09918.x. ISSN 0001-690X. PMID 9272198. S2CID 23485112.
Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Lader M, Tylee A, Donoghue J (2009). "Withdrawing benzodiazepines in primary care". CNS Drugs. 23 (1): 19–34. doi:10.2165/0023210-200923010-00002. PMID 19062773. S2CID 113206.
Hayes, Peggy E.; Schulz, S. Charles (1987). "Beta-blockers in anxiety disorders". Journal of Affective Disorders. 13 (2): 119–30. doi:10.1016/0165-0327(87)90017-6. PMID 2890677.
Jefferson, James W. (1974). "Beta-Adrenergic Receptor Blocking Drugs in Psychiatry". Archives of General Psychiatry. 31 (5): 681–91. doi:10.1001/archpsyc.1974.01760170071012. PMID 4155284.
Koola, M. M.; Varghese, S. P.; Fawcett, J. A. (2013). "High-dose prazosin for the treatment of post-traumatic stress disorder". Therapeutic Advances in Psychopharmacology. 4 (1): 43–7. doi:10.1177/2045125313500982. PMC 3896131. PMID 24490030.
Hoehn-Saric, Rudolf; Merchant, A. F.; Keyser, M. L.; Smith, V. K. (1981). "Effects of Clonidine on Anxiety Disorders". Archives of General Psychiatry. 38 (11): 1278–82. doi:10.1001/archpsyc.1981.01780360094011. PMID 7305609.
DeMartinis, N.; Rynn, M.; Rickels, K.; Mandos, L. (February 2000). "Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder". The Journal of Clinical Psychiatry. 61 (2): 91–94. doi:10.4088/jcp.v61n0203. ISSN 0160-6689. PMID 10732655.
Bandelow, Borwin; Wedekind, Dirk; Leon, Teresa (2014). "Pregabalin for the treatment of generalized anxiety disorder: A novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–81. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Owen, R.T. (2007). "Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today. 43 (9): 601–10. doi:10.1358/dot.2007.43.9.1133188. PMID 17940637.
Llorca, Pierre-Michel; Spadone, Christian; Sol, Olivier; Danniau, Anne; Bougerol, Thierry; Corruble, Emmanuelle; Faruch, Michel; Macher, Jean-Paul; Sermet, Eric; Servant, Dominique (2002). "Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder". The Journal of Clinical Psychiatry. 63 (11): 1020–7. doi:10.4088/JCP.v63n1112. PMID 12444816.
Lapin, Izyaslav (2001). "Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug". CNS Drug Reviews. 7 (4): 471–481. doi:10.1111/j.1527-3458.2001.tb00211.x. ISSN 1527-3458. PMC 6494145. PMID 11830761.
Zvejniece, Liga; Vavers, Edijs; Svalbe, Baiba; Veinberg, Grigory; Rizhanova, Kristina; Liepins, Vilnis; Kalvinsh, Ivars; Dambrova, Maija (1 October 2015). "R-phenibut binds to the α2–δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology Biochemistry and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. ISSN 0091-3057. PMID 26234470. S2CID 42606053.
Owen, David R.; Wood, David M.; Archer, John R. H.; Dargan, Paul I. (2016). "Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity". Drug and Alcohol Review. 35 (5): 591–596. doi:10.1111/dar.12356. hdl:10044/1/30073. ISSN 1465-3362. PMID 26693960.
Cohen, Pieter A.; Ellison, Ross R.; Travis, John C.; Gaufberg, Slava V.; Gerona, Roy (22 September 2021). "Quantity of phenibut in dietary supplements before and after FDA warnings". Clinical Toxicology. 60 (4): 486–488. doi:10.1080/15563650.2021.1973020. PMID 34550038. S2CID 237594860.
Vakhitova, Yu. V.; Yamidanov, R. S.; Vakhitov, V. A.; Seredenin, S. B. (2005). "The effect of ladasten on gene expression in the rat brain". Doklady Biochemistry and Biophysics. 401 (1–6): 150–153. doi:10.1007/s10628-005-0057-z. ISSN 1607-6729. PMID 15999825. S2CID 28048257.
Volchegorskii, I. A.; Miroshnichenko, I. Yu.; Rassokhina, L. M.; Faizullin, R. M.; Malkin, M. P.; Pryakhina, K. E.; Kalugina, A. V. (2015). "Comparative Analysis of the Anxiolytic Effects of 3-Hydroxypyridine and Succinic Acid Derivatives". Bulletin of Experimental Biology and Medicine. 158 (6): 756–61. doi:10.1007/s10517-015-2855-3. PMID 25894772. S2CID 6052275.
Rumyantseva, S. A.; Fedin, A. I.; Sokhova, O. N. (2012). "Antioxidant Treatment of Ischemic Brain Lesions". Neuroscience and Behavioral Physiology. 42 (8): 842–5. doi:10.1007/s11055-012-9646-3. S2CID 39971165. INIST 26388033.
Malykh, Andrei G.; Sadaie, M. Reza (2010). "Piracetam and Piracetam-Like Drugs". Drugs. 70 (3): 287–312. doi:10.2165/11319230-000000000-00000. PMID 20166767. S2CID 12176745.
Skolnick P (November 2012). "Anxioselective anxiolytics: on a quest for the Holy Grail". Trends Pharmacol Sci. 33 (11): 611–20. doi:10.1016/j.tips.2012.08.003. PMC 3482271. PMID 22981367.
Nuss, Philippe; Ferreri, Florian; Bourin, Michel (2019). "An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action (Review)". Neuropsychiatric Disease and Treatment. 15: 1781–1795. doi:10.2147/ndt.s200568. ISSN 1178-2021. PMC 6615018. PMID 31308671.
Gilman, J. M.; Ramchandani, V. A.; Davis, M. B.; Bjork, J. M.; Hommer, D. W. (2008). "Why We Like to Drink: A Functional Magnetic Resonance Imaging Study of the Rewarding and Anxiolytic Effects of Alcohol". Journal of Neuroscience. 28 (18): 4583–91. doi:10.1523/JNEUROSCI.0086-08.2008. PMC 2730732. PMID 18448634.
Shearer, Steven L. (2007). "Recent Advances in the Understanding and Treatment of Anxiety Disorders". Primary Care: Clinics in Office Practice. 34 (3): 475–504, v–vi. doi:10.1016/j.pop.2007.05.002. PMID 17868756.
Pull, Charles B (2007). "Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders". Current Opinion in Psychiatry. 20 (1): 30–5. doi:10.1097/YCO.0b013e3280115e52. PMID 17143079. S2CID 43737803.

dx.doi.org

Hillhouse, Todd M.; Porter, Joseph H. (2015). "A brief history of the development of antidepressant drugs: From monoamines to glutamate". Experimental and Clinical Psychopharmacology. 23 (1): 1–21. doi:10.1037/a0038550. ISSN 1936-2293. PMC 4428540. PMID 25643025.
"Rang and Dale's Pharmacology 7th Edition Preface", Rang &amp Dale's Pharmacology, Elsevier, pp. xv, 2012, doi:10.1016/b978-0-7020-3471-8.00064-0, ISBN 9780702034718, retrieved 16 March 2022
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety disorders". Generalized Anxiety Disorders. 19 (2): 93–107. doi:10.31887/dcns.2017.19.2/bbandelow. ISSN 2608-3477. PMC 5573566. PMID 28867934.

farmak.ua

"Farmak Product Information - Validol" (PDF). Archived from the original (PDF) on 19 December 2013. Retrieved 9 April 2013.

handle.net

hdl.handle.net

Owen, David R.; Wood, David M.; Archer, John R. H.; Dargan, Paul I. (2016). "Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity". Drug and Alcohol Review. 35 (5): 591–596. doi:10.1111/dar.12356. hdl:10044/1/30073. ISSN 1465-3362. PMID 26693960.

inist.fr

pascal-francis.inist.fr

Rumyantseva, S. A.; Fedin, A. I.; Sokhova, O. N. (2012). "Antioxidant Treatment of Ischemic Brain Lesions". Neuroscience and Behavioral Physiology. 42 (8): 842–5. doi:10.1007/s11055-012-9646-3. S2CID 39971165. INIST 26388033.

klarityadhd.com

"BuSpar For Anxiety: Is It Right For Me? | Klarity". www.klarityadhd.com. 23 November 2022. Retrieved 19 October 2023.

mayoclinic.org

"Tricyclic antidepressants (TCAs)". Mayo Clinic.

nhs.uk

"Side effects - Selective serotonin reuptake inhibitors (SSRIs)". nhs.uk. 15 February 2021. Retrieved 15 January 2024.

nih.gov

pubmed.ncbi.nlm.nih.gov

Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Van Der Walt, Martie; Keddy, Karen H. (1 June 2021). "The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future". Frontiers in Psychiatry. 12: 617751. doi:10.3389/fpsyt.2021.617751. ISSN 1664-0640. PMC 8203803. PMID 34140898.
Hillhouse, Todd M.; Porter, Joseph H. (2015). "A brief history of the development of antidepressant drugs: From monoamines to glutamate". Experimental and Clinical Psychopharmacology. 23 (1): 1–21. doi:10.1037/a0038550. ISSN 1936-2293. PMC 4428540. PMID 25643025.
Moraczewski, Jordan; Awosika, Ayoola O.; Aedma, Kapil K. (2023), "Tricyclic Antidepressants", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491723, retrieved 15 January 2024
Garakani, Amir; Murrough, James W.; Freire, Rafael C.; Thom, Robyn P.; Larkin, Kaitlyn; Buono, Frank D.; Iosifescu, Dan V. (2020). "Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options". Frontiers in Psychiatry. 11. doi:10.3389/fpsyt.2020.595584. ISSN 1664-0640. PMC 7786299. PMID 33424664.
Kanba, S. (2004). "Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?". Journal of Psychiatry & Neuroscience. 29 (6): 485. PMC 524966. PMID 15644990.
Lochmann, Dee; Richardson, Tara (2018), Macaluso, Matthew; Preskorn, Sheldon H. (eds.), "Selective Serotonin Reuptake Inhibitors", Antidepressants, vol. 250, Cham: Springer International Publishing, pp. 135–144, doi:10.1007/164_2018_172, ISBN 978-3-030-10948-6, PMID 30838457, retrieved 16 March 2022
Dunlop, Boadie W.; Davis, Paula G. (2008). "Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review". Primary Care Companion to The Journal of Clinical Psychiatry. 10 (3): 222–228. ISSN 1523-5998. PMC 2446479. PMID 18615162.
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety disorders". Generalized Anxiety Disorders. 19 (2): 93–107. doi:10.31887/dcns.2017.19.2/bbandelow. ISSN 2608-3477. PMC 5573566. PMID 28867934.
Thanacoody, H. K. Ruben; Thomas, Simon H. L. (2005). "Tricyclic antidepressant poisoning : cardiovascular toxicity". Toxicological Reviews. 24 (3): 205–214. doi:10.2165/00139709-200524030-00013. ISSN 1176-2551. PMID 16390222. S2CID 44532041.
Montano, C. Brendan; Jackson, W. Clay; Vanacore, Denise; Weisler, Richard (4 July 2023). "Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression". Postgraduate Medicine. 135 (5): 449–465. doi:10.1080/00325481.2023.2189868. ISSN 0032-5481. PMID 36912037.
Tanghe, A.; Geerts, S.; Van Dorpe, J.; Brichard, B.; Bruhwyler, J.; Géczy, J. (August 1997). "Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression". Acta Psychiatrica Scandinavica. 96 (2): 134–141. doi:10.1111/j.1600-0447.1997.tb09918.x. ISSN 0001-690X. PMID 9272198. S2CID 23485112.
Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Lader M, Tylee A, Donoghue J (2009). "Withdrawing benzodiazepines in primary care". CNS Drugs. 23 (1): 19–34. doi:10.2165/0023210-200923010-00002. PMID 19062773. S2CID 113206.
Hayes, Peggy E.; Schulz, S. Charles (1987). "Beta-blockers in anxiety disorders". Journal of Affective Disorders. 13 (2): 119–30. doi:10.1016/0165-0327(87)90017-6. PMID 2890677.
Jefferson, James W. (1974). "Beta-Adrenergic Receptor Blocking Drugs in Psychiatry". Archives of General Psychiatry. 31 (5): 681–91. doi:10.1001/archpsyc.1974.01760170071012. PMID 4155284.
Koola, M. M.; Varghese, S. P.; Fawcett, J. A. (2013). "High-dose prazosin for the treatment of post-traumatic stress disorder". Therapeutic Advances in Psychopharmacology. 4 (1): 43–7. doi:10.1177/2045125313500982. PMC 3896131. PMID 24490030.
Hoehn-Saric, Rudolf; Merchant, A. F.; Keyser, M. L.; Smith, V. K. (1981). "Effects of Clonidine on Anxiety Disorders". Archives of General Psychiatry. 38 (11): 1278–82. doi:10.1001/archpsyc.1981.01780360094011. PMID 7305609.
DeMartinis, N.; Rynn, M.; Rickels, K.; Mandos, L. (February 2000). "Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder". The Journal of Clinical Psychiatry. 61 (2): 91–94. doi:10.4088/jcp.v61n0203. ISSN 0160-6689. PMID 10732655.
Bandelow, Borwin; Wedekind, Dirk; Leon, Teresa (2014). "Pregabalin for the treatment of generalized anxiety disorder: A novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–81. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Owen, R.T. (2007). "Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today. 43 (9): 601–10. doi:10.1358/dot.2007.43.9.1133188. PMID 17940637.
Llorca, Pierre-Michel; Spadone, Christian; Sol, Olivier; Danniau, Anne; Bougerol, Thierry; Corruble, Emmanuelle; Faruch, Michel; Macher, Jean-Paul; Sermet, Eric; Servant, Dominique (2002). "Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder". The Journal of Clinical Psychiatry. 63 (11): 1020–7. doi:10.4088/JCP.v63n1112. PMID 12444816.
Lapin, Izyaslav (2001). "Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug". CNS Drug Reviews. 7 (4): 471–481. doi:10.1111/j.1527-3458.2001.tb00211.x. ISSN 1527-3458. PMC 6494145. PMID 11830761.
Zvejniece, Liga; Vavers, Edijs; Svalbe, Baiba; Veinberg, Grigory; Rizhanova, Kristina; Liepins, Vilnis; Kalvinsh, Ivars; Dambrova, Maija (1 October 2015). "R-phenibut binds to the α2–δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology Biochemistry and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. ISSN 0091-3057. PMID 26234470. S2CID 42606053.
Owen, David R.; Wood, David M.; Archer, John R. H.; Dargan, Paul I. (2016). "Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity". Drug and Alcohol Review. 35 (5): 591–596. doi:10.1111/dar.12356. hdl:10044/1/30073. ISSN 1465-3362. PMID 26693960.
Cohen, Pieter A.; Ellison, Ross R.; Travis, John C.; Gaufberg, Slava V.; Gerona, Roy (22 September 2021). "Quantity of phenibut in dietary supplements before and after FDA warnings". Clinical Toxicology. 60 (4): 486–488. doi:10.1080/15563650.2021.1973020. PMID 34550038. S2CID 237594860.
Val'dman AV, Zaikonnikova IV, Kozlovskaia MM, Zimakova IE (1980). "[Characteristics of the psychotropic spectrum of action of mebicar]". Biulleten' Eksperimental'noĭ Biologii I Meditsiny (in Russian). 89 (5): 568–70. PMID 6104993.
Neznamov, GG; Siuniakov, SA; Chumakov, DV; Bochkarev, VK; Seredenin, SB (2001). "Clinical study of the selective anxiolytic agent afobazol". Eksperimental'naia i Klinicheskaia Farmakologiia. 64 (2): 15–9. PMID 11548440.
Silkina, IV; Gan'shina, TC; Seredin, SB; Mirzoian, RS (2005). "Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon". Eksperimental'naia i Klinicheskaia Farmakologiia. 68 (1): 20–4. PMID 15786959.
Vakhitova IuV, Iamidanov RS, Seredinin SB (2004). "[Ladasten induces the expression of genes regulating dopamine biosynthesis in various structures of rat brain]". Eksp Klin Farmakol (in Russian). 67 (4): 7–11. PMID 15500036.
Vakhitova, Yu. V.; Yamidanov, R. S.; Vakhitov, V. A.; Seredenin, S. B. (2005). "The effect of ladasten on gene expression in the rat brain". Doklady Biochemistry and Biophysics. 401 (1–6): 150–153. doi:10.1007/s10628-005-0057-z. ISSN 1607-6729. PMID 15999825. S2CID 28048257.
Volchegorskii, I. A.; Miroshnichenko, I. Yu.; Rassokhina, L. M.; Faizullin, R. M.; Malkin, M. P.; Pryakhina, K. E.; Kalugina, A. V. (2015). "Comparative Analysis of the Anxiolytic Effects of 3-Hydroxypyridine and Succinic Acid Derivatives". Bulletin of Experimental Biology and Medicine. 158 (6): 756–61. doi:10.1007/s10517-015-2855-3. PMID 25894772. S2CID 6052275.
Malykh, Andrei G.; Sadaie, M. Reza (2010). "Piracetam and Piracetam-Like Drugs". Drugs. 70 (3): 287–312. doi:10.2165/11319230-000000000-00000. PMID 20166767. S2CID 12176745.
Skolnick P (November 2012). "Anxioselective anxiolytics: on a quest for the Holy Grail". Trends Pharmacol Sci. 33 (11): 611–20. doi:10.1016/j.tips.2012.08.003. PMC 3482271. PMID 22981367.
Nuss, Philippe; Ferreri, Florian; Bourin, Michel (2019). "An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action (Review)". Neuropsychiatric Disease and Treatment. 15: 1781–1795. doi:10.2147/ndt.s200568. ISSN 1178-2021. PMC 6615018. PMID 31308671.
Gilman, J. M.; Ramchandani, V. A.; Davis, M. B.; Bjork, J. M.; Hommer, D. W. (2008). "Why We Like to Drink: A Functional Magnetic Resonance Imaging Study of the Rewarding and Anxiolytic Effects of Alcohol". Journal of Neuroscience. 28 (18): 4583–91. doi:10.1523/JNEUROSCI.0086-08.2008. PMC 2730732. PMID 18448634.
Shearer, Steven L. (2007). "Recent Advances in the Understanding and Treatment of Anxiety Disorders". Primary Care: Clinics in Office Practice. 34 (3): 475–504, v–vi. doi:10.1016/j.pop.2007.05.002. PMID 17868756.
Pull, Charles B (2007). "Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders". Current Opinion in Psychiatry. 20 (1): 30–5. doi:10.1097/YCO.0b013e3280115e52. PMID 17143079. S2CID 43737803.

ncbi.nlm.nih.gov

Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Van Der Walt, Martie; Keddy, Karen H. (1 June 2021). "The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future". Frontiers in Psychiatry. 12: 617751. doi:10.3389/fpsyt.2021.617751. ISSN 1664-0640. PMC 8203803. PMID 34140898.
Hillhouse, Todd M.; Porter, Joseph H. (2015). "A brief history of the development of antidepressant drugs: From monoamines to glutamate". Experimental and Clinical Psychopharmacology. 23 (1): 1–21. doi:10.1037/a0038550. ISSN 1936-2293. PMC 4428540. PMID 25643025.
Moraczewski, Jordan; Awosika, Ayoola O.; Aedma, Kapil K. (2023), "Tricyclic Antidepressants", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491723, retrieved 15 January 2024
Garakani, Amir; Murrough, James W.; Freire, Rafael C.; Thom, Robyn P.; Larkin, Kaitlyn; Buono, Frank D.; Iosifescu, Dan V. (2020). "Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options". Frontiers in Psychiatry. 11. doi:10.3389/fpsyt.2020.595584. ISSN 1664-0640. PMC 7786299. PMID 33424664.
Kanba, S. (2004). "Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?". Journal of Psychiatry & Neuroscience. 29 (6): 485. PMC 524966. PMID 15644990.
Dunlop, Boadie W.; Davis, Paula G. (2008). "Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review". Primary Care Companion to The Journal of Clinical Psychiatry. 10 (3): 222–228. ISSN 1523-5998. PMC 2446479. PMID 18615162.
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety disorders". Generalized Anxiety Disorders. 19 (2): 93–107. doi:10.31887/dcns.2017.19.2/bbandelow. ISSN 2608-3477. PMC 5573566. PMID 28867934.
Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Koola, M. M.; Varghese, S. P.; Fawcett, J. A. (2013). "High-dose prazosin for the treatment of post-traumatic stress disorder". Therapeutic Advances in Psychopharmacology. 4 (1): 43–7. doi:10.1177/2045125313500982. PMC 3896131. PMID 24490030.
Lapin, Izyaslav (2001). "Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug". CNS Drug Reviews. 7 (4): 471–481. doi:10.1111/j.1527-3458.2001.tb00211.x. ISSN 1527-3458. PMC 6494145. PMID 11830761.
Skolnick P (November 2012). "Anxioselective anxiolytics: on a quest for the Holy Grail". Trends Pharmacol Sci. 33 (11): 611–20. doi:10.1016/j.tips.2012.08.003. PMC 3482271. PMID 22981367.
Nuss, Philippe; Ferreri, Florian; Bourin, Michel (2019). "An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action (Review)". Neuropsychiatric Disease and Treatment. 15: 1781–1795. doi:10.2147/ndt.s200568. ISSN 1178-2021. PMC 6615018. PMID 31308671.
Gilman, J. M.; Ramchandani, V. A.; Davis, M. B.; Bjork, J. M.; Hommer, D. W. (2008). "Why We Like to Drink: A Functional Magnetic Resonance Imaging Study of the Rewarding and Anxiolytic Effects of Alcohol". Journal of Neuroscience. 28 (18): 4583–91. doi:10.1523/JNEUROSCI.0086-08.2008. PMC 2730732. PMID 18448634.

olainfarm.lv

"Adaptol. Summary of Product Characteristics" (PDF). Archived from the original (PDF) on 3 December 2015. Retrieved 24 July 2015.

psychcentral.com

"What is the Best Anticonvulsant for Anxiety?". Psych Central. 28 October 2014. Retrieved 19 October 2023.

rmj.ru

журнал», Издание для практикующих врачей «Русский медицинский. "Феномен аминофенилмасляной кислоты". www.rmj.ru. Retrieved 19 December 2018.

semanticscholar.org

api.semanticscholar.org

Thanacoody, H. K. Ruben; Thomas, Simon H. L. (2005). "Tricyclic antidepressant poisoning : cardiovascular toxicity". Toxicological Reviews. 24 (3): 205–214. doi:10.2165/00139709-200524030-00013. ISSN 1176-2551. PMID 16390222. S2CID 44532041.
Tanghe, A.; Geerts, S.; Van Dorpe, J.; Brichard, B.; Bruhwyler, J.; Géczy, J. (August 1997). "Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression". Acta Psychiatrica Scandinavica. 96 (2): 134–141. doi:10.1111/j.1600-0447.1997.tb09918.x. ISSN 0001-690X. PMID 9272198. S2CID 23485112.
Lader M, Tylee A, Donoghue J (2009). "Withdrawing benzodiazepines in primary care". CNS Drugs. 23 (1): 19–34. doi:10.2165/0023210-200923010-00002. PMID 19062773. S2CID 113206.
Bandelow, Borwin; Wedekind, Dirk; Leon, Teresa (2014). "Pregabalin for the treatment of generalized anxiety disorder: A novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–81. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Zvejniece, Liga; Vavers, Edijs; Svalbe, Baiba; Veinberg, Grigory; Rizhanova, Kristina; Liepins, Vilnis; Kalvinsh, Ivars; Dambrova, Maija (1 October 2015). "R-phenibut binds to the α2–δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology Biochemistry and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. ISSN 0091-3057. PMID 26234470. S2CID 42606053.
Cohen, Pieter A.; Ellison, Ross R.; Travis, John C.; Gaufberg, Slava V.; Gerona, Roy (22 September 2021). "Quantity of phenibut in dietary supplements before and after FDA warnings". Clinical Toxicology. 60 (4): 486–488. doi:10.1080/15563650.2021.1973020. PMID 34550038. S2CID 237594860.
Vakhitova, Yu. V.; Yamidanov, R. S.; Vakhitov, V. A.; Seredenin, S. B. (2005). "The effect of ladasten on gene expression in the rat brain". Doklady Biochemistry and Biophysics. 401 (1–6): 150–153. doi:10.1007/s10628-005-0057-z. ISSN 1607-6729. PMID 15999825. S2CID 28048257.
Volchegorskii, I. A.; Miroshnichenko, I. Yu.; Rassokhina, L. M.; Faizullin, R. M.; Malkin, M. P.; Pryakhina, K. E.; Kalugina, A. V. (2015). "Comparative Analysis of the Anxiolytic Effects of 3-Hydroxypyridine and Succinic Acid Derivatives". Bulletin of Experimental Biology and Medicine. 158 (6): 756–61. doi:10.1007/s10517-015-2855-3. PMID 25894772. S2CID 6052275.
Rumyantseva, S. A.; Fedin, A. I.; Sokhova, O. N. (2012). "Antioxidant Treatment of Ischemic Brain Lesions". Neuroscience and Behavioral Physiology. 42 (8): 842–5. doi:10.1007/s11055-012-9646-3. S2CID 39971165. INIST 26388033.
Malykh, Andrei G.; Sadaie, M. Reza (2010). "Piracetam and Piracetam-Like Drugs". Drugs. 70 (3): 287–312. doi:10.2165/11319230-000000000-00000. PMID 20166767. S2CID 12176745.
Pull, Charles B (2007). "Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders". Current Opinion in Psychiatry. 20 (1): 30–5. doi:10.1097/YCO.0b013e3280115e52. PMID 17143079. S2CID 43737803.

springer.com

link.springer.com

Lochmann, Dee; Richardson, Tara (2018), Macaluso, Matthew; Preskorn, Sheldon H. (eds.), "Selective Serotonin Reuptake Inhibitors", Antidepressants, vol. 250, Cham: Springer International Publishing, pp. 135–144, doi:10.1007/164_2018_172, ISBN 978-3-030-10948-6, PMID 30838457, retrieved 16 March 2022

thefreedictionary.com

encyclopedia2.thefreedictionary.com

"Validol". The Great Soviet Encyclopedia.

web.archive.org

"Antianxiety agent" at Dorland's Medical Dictionary
"Adaptol. Summary of Product Characteristics" (PDF). Archived from the original (PDF) on 3 December 2015. Retrieved 24 July 2015.
"Farmak Product Information - Validol" (PDF). Archived from the original (PDF) on 19 December 2013. Retrieved 9 April 2013.

worldcat.org

search.worldcat.org

Whittlesea, Cate; Hodson, Karen, eds. (7 August 2018). Clinical pharmacy and therapeutics. Elsevier. ISBN 978-0-7020-7012-9. OCLC 1084882482.
Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
Van Der Walt, Martie; Keddy, Karen H. (1 June 2021). "The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future". Frontiers in Psychiatry. 12: 617751. doi:10.3389/fpsyt.2021.617751. ISSN 1664-0640. PMC 8203803. PMID 34140898.
Hillhouse, Todd M.; Porter, Joseph H. (2015). "A brief history of the development of antidepressant drugs: From monoamines to glutamate". Experimental and Clinical Psychopharmacology. 23 (1): 1–21. doi:10.1037/a0038550. ISSN 1936-2293. PMC 4428540. PMID 25643025.
Garakani, Amir; Murrough, James W.; Freire, Rafael C.; Thom, Robyn P.; Larkin, Kaitlyn; Buono, Frank D.; Iosifescu, Dan V. (2020). "Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options". Frontiers in Psychiatry. 11. doi:10.3389/fpsyt.2020.595584. ISSN 1664-0640. PMC 7786299. PMID 33424664.
Barlow, David H.; Durand, Mark V (2009). "Chapter 7: Mood Disorders and Suicide". Abnormal Psychology: An Integrative Approach (Fifth ed.). Belmont, CA: Wadsworth Cengage Learning. p. 239. ISBN 978-0-495-09556-9. OCLC 192055408.^{[page needed]}
Dunlop, Boadie W.; Davis, Paula G. (2008). "Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review". Primary Care Companion to The Journal of Clinical Psychiatry. 10 (3): 222–228. ISSN 1523-5998. PMC 2446479. PMID 18615162.
Formulary., Committee, Joint (2014). British National Formulary. Pharmaceutical Press. ISBN 978-0-85711-152-4. OCLC 874322467.{{cite book}}: CS1 maint: multiple names: authors list (link)
Stahl, Stephen M. (2011). Stahl's essential psychopharmacology : the prescriber's guide. Meghan M. Grady (4th ed.). Cambridge, UK: Cambridge University Press. ISBN 978-0-521-17364-3. OCLC 701672553.
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety disorders". Generalized Anxiety Disorders. 19 (2): 93–107. doi:10.31887/dcns.2017.19.2/bbandelow. ISSN 2608-3477. PMC 5573566. PMID 28867934.
Thanacoody, H. K. Ruben; Thomas, Simon H. L. (2005). "Tricyclic antidepressant poisoning : cardiovascular toxicity". Toxicological Reviews. 24 (3): 205–214. doi:10.2165/00139709-200524030-00013. ISSN 1176-2551. PMID 16390222. S2CID 44532041.
Montano, C. Brendan; Jackson, W. Clay; Vanacore, Denise; Weisler, Richard (4 July 2023). "Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression". Postgraduate Medicine. 135 (5): 449–465. doi:10.1080/00325481.2023.2189868. ISSN 0032-5481. PMID 36912037.
Tanghe, A.; Geerts, S.; Van Dorpe, J.; Brichard, B.; Bruhwyler, J.; Géczy, J. (August 1997). "Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression". Acta Psychiatrica Scandinavica. 96 (2): 134–141. doi:10.1111/j.1600-0447.1997.tb09918.x. ISSN 0001-690X. PMID 9272198. S2CID 23485112.
Burchum, Jacqueline Rosenjack; Rosenthal, Laura D. (29 January 2015). Lehne's pharmacology for nursing care (9th ed.). St. Louis, Missouri. ISBN 9780323321907. OCLC 890310283.{{cite book}}: CS1 maint: location missing publisher (link)
Cassano, Giovanni B.; Rossi, Nicolò Baldini; Pini, Stefano (2002). "Psychopharmacology of anxiety disorders". Dialogues in Clinical Neuroscience. 4 (3): 271–285. doi:10.31887/DCNS.2002.4.3/gcassano. ISSN 1294-8322. PMC 3181684. PMID 22033867.
DeMartinis, N.; Rynn, M.; Rickels, K.; Mandos, L. (February 2000). "Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder". The Journal of Clinical Psychiatry. 61 (2): 91–94. doi:10.4088/jcp.v61n0203. ISSN 0160-6689. PMID 10732655.
Lapin, Izyaslav (2001). "Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug". CNS Drug Reviews. 7 (4): 471–481. doi:10.1111/j.1527-3458.2001.tb00211.x. ISSN 1527-3458. PMC 6494145. PMID 11830761.
Zvejniece, Liga; Vavers, Edijs; Svalbe, Baiba; Veinberg, Grigory; Rizhanova, Kristina; Liepins, Vilnis; Kalvinsh, Ivars; Dambrova, Maija (1 October 2015). "R-phenibut binds to the α2–δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects". Pharmacology Biochemistry and Behavior. 137: 23–29. doi:10.1016/j.pbb.2015.07.014. ISSN 0091-3057. PMID 26234470. S2CID 42606053.
Owen, David R.; Wood, David M.; Archer, John R. H.; Dargan, Paul I. (2016). "Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity". Drug and Alcohol Review. 35 (5): 591–596. doi:10.1111/dar.12356. hdl:10044/1/30073. ISSN 1465-3362. PMID 26693960.
Vakhitova, Yu. V.; Yamidanov, R. S.; Vakhitov, V. A.; Seredenin, S. B. (2005). "The effect of ladasten on gene expression in the rat brain". Doklady Biochemistry and Biophysics. 401 (1–6): 150–153. doi:10.1007/s10628-005-0057-z. ISSN 1607-6729. PMID 15999825. S2CID 28048257.
Nuss, Philippe; Ferreri, Florian; Bourin, Michel (2019). "An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action (Review)". Neuropsychiatric Disease and Treatment. 15: 1781–1795. doi:10.2147/ndt.s200568. ISSN 1178-2021. PMC 6615018. PMID 31308671.

worldcat.org

Whittlesea, Cate; Hodson, Karen, eds. (7 August 2018). Clinical pharmacy and therapeutics. Elsevier. ISBN 978-0-7020-7012-9. OCLC 1084882482.
Formulary., Committee, Joint (2014). British National Formulary. Pharmaceutical Press. ISBN 978-0-85711-152-4. OCLC 874322467.{{cite book}}: CS1 maint: multiple names: authors list (link)
Stahl, Stephen M. (2011). Stahl's essential psychopharmacology : the prescriber's guide. Meghan M. Grady (4th ed.). Cambridge, UK: Cambridge University Press. ISBN 978-0-521-17364-3. OCLC 701672553.

zenodo.org

Hayes, Peggy E.; Schulz, S. Charles (1987). "Beta-blockers in anxiety disorders". Journal of Affective Disorders. 13 (2): 119–30. doi:10.1016/0165-0327(87)90017-6. PMID 2890677.